Quantcast

Latest emphysema Stories

2011-04-13 21:53:46

Stimulating lung's defenses against bacterial infection Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung's innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease (COPD). In a study published in the April 13 edition of the journal Science Translational Medicine, the Johns Hopkins researchers targeted the Nrf2 pathway using sulforaphane,...

2011-03-21 07:27:31

(Ivanhoe Newswire) "“ Emphysema, an untreatable lung disease, and a significant cause of disability and death in the United States, will soon be detected early among smokers before symptoms appear. According to the American Journal of Respiratory and Critical Care Medicine, Researchers at New York "“ Presbyterian Hospital/Weill Cornell Medical Center say an early-detection simple blood test for emphysema may be offered in the future. Most cases of emphysema are caused by smoking;...

2011-03-18 07:59:55

(Ivanhoe Newswire) -- Smokers with interstitial lung abnormalities on high-resolution CT show both reduced total lung capacity and a lesser amount of emphysema, compared with those who didn't have interstitial lung abnormalities. In addition, the magnitude of these two reductions is greatest among smokers who also have chronic obstructive pulmonary disease (COPD), said Dr. George R. Washko of the pulmonary and critical care division at Brigham and Women's Hospital and Harvard Medical School,...

2011-03-11 16:04:50

Monitoring blood for tiny particles released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages, according to researchers from Weill Cornell Medical College. The particles, called endothelial microparticles (EMPs), are shed during the disease process as tiny blood vessels in the lungs, called pulmonary capillaries, are injured and die. The findings were published online ahead of the print edition of the American Thoracic Society's American Journal of...

2011-03-11 14:20:37

Researchers say the test, which measures destruction of lung air sacs, could help prevent progression of the common, and fatal, lung disease During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood test that detects the early development of emphysema -- well before symptoms occur -- may someday also be offered. In the March 11 online...

2011-03-10 13:26:49

A team of researchers at Brigham and Women's Hospital (BWH) have found that approximately one out of every twelve adult smokers have abnormal lung densities present on chest computed tomography (CT) images suggestive of interstitial lung disease which is associated with substantial reductions in lung volumes. In addition, despite being positively associated with smoking, these lung densities were inversely not associated with emphysema. This research is published online on March 10th in the...

2011-03-01 10:36:00

Editor's note: Daliresp has been approved as the trade name for roflumilast. SILVER SPRING, Md., March 1, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups (exacerbations) or worsening of symptoms from severe chronic obstructive pulmonary disease (COPD). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) COPD is a serious lung disease that makes breathing difficult. Symptoms...

2011-03-01 09:02:00

Editor's note: A trade name for roflumilast was not available at the time of approval. SILVER SPRING, Md., March 1, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups (exacerbations) or worsening of symptoms from severe chronic obstructive pulmonary disease (COPD). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) COPD is a serious lung disease that makes breathing difficult....

2011-03-01 07:17:00

IRVINE, Calif., March 1, 2011 /PRNewswire/ -- Uptake Medical® Corp., a developer of medical technologies for the non-surgical treatment of lung diseases including emphysema, announced today that Scott Huennekens, President and CEO of Volcano Corporation, (Nasdaq: VOLC) has joined the company's Board of Directors. Mr. Huennekens has served as President, CEO and Director of Volcano since April 2002. He led the company from a pre-revenue start-up to its IPO in 2006 and its...

2011-01-18 14:51:10

Researchers from Duke University Medical Center have identified how nanoparticles from diesel exhaust damage lung airway cells, a finding that could lead to new therapies for people susceptible to airway disease. The scientists also discovered that the severity of the injury depends on the genetic make-up of the affected individual. "We gained insight into why some people can remain relatively healthy in polluted areas and why others don't," said lead author Wolfgang Liedtke, M.D., Ph.D.,...


Latest emphysema Reference Libraries

Lung
2013-01-01 15:53:59

The lung is a vital organ that is a part of the respiratory system. Generally a person has two lungs; however, the body can function with only one. The lung’s main function is to move oxygen and carbon dioxide into and out of the bloodstream through gas exchange. The lungs are located lateral to the heart in the thoracic cavity. Each lung has a tip called the apex, which is superior in the body. The bases of the lungs rest on the diaphragm. They appear to be spongy due to their bundles of...

More Articles (1 articles) »
Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related